Daniel Falkenhain-López

16PUBLICATIONS
36CO-AUTHORS
Medical mycologyAllergyHaematological tumoursElectrochemistryRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 23, 2023
Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.

C A Rubio-Muniz, A Sánchez-Velázquez, J Arroyo-Andrés

|Jun 15, 2022
Apremilast: A novel adjuvant treatment for refractory isotretinoin-induced acne fulminans.

Alba Sánchez-Velázquez, Daniel Falkenhain-López, Jorge Arroyo-Andrés

|Apr 15, 2022
Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas.

Daniel Falkenhain-López, Mario Puerta-Peña, Jon Fulgencio-Barbarin

|Feb 10, 2022
Drug reaction with eosinophilia and systemic symptoms in a 10-year-old boy sparing lichen planus lesions: an example of reverse isotopic response.

V Velasco-Tamariz, D Falkenhain-López, M Penalba-Torres

|Feb 08, 2022
Two clinical subtypes with different management of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single centre experience.

Daniel Falkenhain-López, Alba Sánchez-Velázquez, Jon Fulgencio-Barbarin

|Jan 24, 2022
Urticarial vasculitis with positive skin polymerase chain reaction for Coxiella burnetii: an unusual manifestation of Q fever.

Daniel Falkenhain-López, Jesús Alonso-Carrillo, Miguel A Verdejo

Pageof 3

Frequent Collaborators

9 joint publications

Alba Sánchez-Velázquez

5 joint publications

Mario Puerta-Peña

3 joint publications

Jon Fulgencio-Barbarin

3 joint publications

Jorge Arroyo-Andrés